Načítá se...
Safety of 3‐Month Dual Antiplatelet Therapy After Implantation of Ultrathin Sirolimus‐Eluting Stents With Biodegradable Polymer (Orsiro): Results From the SMART‐CHOICE Trial
BACKGROUND: This study sought to investigate the safety of 3‐month dual antiplatelet therapy (DAPT) in patients receiving ultrathin sirolimus‐eluting stents with biodegradable polymer (Orsiro). METHODS AND RESULTS: The SMART‐CHOICE (Smart Angioplasty Research Team: Comparison Between P2Y12 Antagonis...
Uloženo v:
| Vydáno v: | J Am Heart Assoc |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7955499/ https://ncbi.nlm.nih.gov/pubmed/33345567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.120.018366 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|